Skandinaviska Enskilda Banken (SEB)
CSTL icon

Skandinaviska Enskilda Banken (SEB)’s Castle Biosciences CSTL Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,300
Closed -$568K – 1063
2021
Q1 		$568K Hold
8,300
– – ﹤0.01% 909
2020
Q4 		$557K Hold
8,300
– – ﹤0.01% 898
2020
Q3 		$427K Sell
8,300
-4,000
-33% -$178K ﹤0.01% 846
2020
Q2 		$464K Buy
+12,300
New +$420K ﹤0.01% 825

Other funds holding CSTL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s CSTL Position: Q2 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Castle Biosciences (CSTL) in Q2 2021, closing a stake of 8,300 shares — an estimated $568K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in CSTL in Q2 2020 and held it in 4 quarters. The position peaked at $568K in Q1 2021. 181 funds tracked by Wall St. Rank hold CSTL as of Q2 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Castle Biosciences position as of Q2 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 8,300 Castle Biosciences shares in Q2 2021, an estimated $568K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Castle Biosciences in Q2 2020 and held it in 4 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Castle Biosciences position peaked at $568K in Q1 2021.
  • 181 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q2 2021, filed 10 Aug 2021.